I

Innocan Pharma Corp
CNSX:INNO

Watchlist Manager
Innocan Pharma Corp
CNSX:INNO
Watchlist
Price: 8 CAD -0.12% Market Closed
Market Cap: 36m CAD

Intrinsic Value

The intrinsic value of one INNO stock under the Base Case scenario is hidden CAD. Compared to the current market price of 8 CAD, Innocan Pharma Corp is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

INNO Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Innocan Pharma Corp

Intrinsic Value History
Dive into the past to invest in the future

INNO looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if INNO is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about INNO?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is INNO valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Innocan Pharma Corp.

Explain Valuation
Compare INNO to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about INNO?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Innocan Pharma Corp

Current Assets 11m
Cash & Short-Term Investments 7.3m
Receivables 787k
Other Current Assets 3m
Non-Current Assets 93k
PP&E 93k
Current Liabilities 3m
Accounts Payable 43k
Accrued Liabilities 599k
Other Current Liabilities 2.3m
Non-Current Liabilities 4.3m
Long-Term Debt 1.5m
Other Non-Current Liabilities 2.8m
Efficiency

Free Cash Flow Analysis
Innocan Pharma Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Innocan Pharma Corp

Revenue
27m USD
Cost of Revenue
-3.1m USD
Gross Profit
23.9m USD
Operating Expenses
-25.2m USD
Operating Income
-1.3m USD
Other Expenses
-2m USD
Net Income
-3.2m USD
Fundamental Scores

INNO Profitability Score
Profitability Due Diligence

Innocan Pharma Corp's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Exceptional Gross Margin
Strong 3Y Average Gross Margin
Operating Margin is Increasing
hidden
Profitability
Score

Innocan Pharma Corp's profitability score is hidden . The higher the profitability score, the more profitable the company is.

INNO Solvency Score
Solvency Due Diligence

Innocan Pharma Corp's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Negative Net Debt
Short-Term Solvency
Low D/E
High Altman Z-Score
hidden
Solvency
Score

Innocan Pharma Corp's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

INNO Price Targets Summary
Innocan Pharma Corp

There are no price targets for INNO.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Innocan Pharma Corp
does not pay dividends
Shareholder Yield

Current shareholder yield for INNO is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one INNO stock?

The intrinsic value of one INNO stock under the Base Case scenario is hidden CAD.

Is INNO stock undervalued or overvalued?

Compared to the current market price of 8 CAD, Innocan Pharma Corp is hidden .

Back to Top